Seventeen patients with localised ccRCC developed recurrence; fourteen of these showed either LOH or somatic copy number loss at CDKN2A (Figure 3: Log-rank: p = 0.005). This evidence concerns the gene CDKN2A and nonpapillary renal cell carcinoma.